Health TrialsbyHealthPanel

Chronic Kidney Disease And Hypertension

2

Review clinical trials related to Chronic Kidney Disease And Hypertension. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

Participants needed: 5,000
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Jun 26, 2026Locations: 764
Eligibility criteria

Participants of any sex and gender must be ≥ 18 years of age at the time of sign... [+10]

Systolic blood pressure > 180 mmHg, or diastolic BP > 110 mmHg at screening. [+4]

Read more
Status: Recruiting

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.

Participants needed: 218
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: May 18, 2026Locations: 71
Eligibility criteria

Participants of any sex and gender must be ≥ 18 years of age at the time of sign... [+7]

Systolic blood pressure > 180 mmHg, or diastolic blood pressure > 110 mmHg at sc... [+12]

Read more